Antitumour effect of Lactobacillus casei CRL 431 on different experimental tumours

Food and Agricultural Immunology

Volumn 16, Issue 3, 2005, Pages 181-191

  Bonet, María Eugenia Bibas ^a   De Petrino, Silvia Fontenla ^a   Mesón, Oscar ^a   Perdigón, Gabriela ^a,b  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Colorectal cancer; Cytokines; Fibrosarcome; Lactobacillus casei

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI;

EID: 27844478811     PISSN: 09540105     EISSN: 14653443     Source Type: Journal    
DOI: 10.1080/09540100500173105     Document Type: Article

References (26)

1. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S and the BPL Study Group. 1995. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Euro Urol 27:104-109.
2. Attia MA, Weiss DW. 1966. Immunology of spontaneous mammary carcinomas in mice. Acquired tumor resistance and enhancement in strain. A mice infected with mammary tumor virus. Cancer Res 26:1787-1792.
3. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22:199-208.
4. De Moreno de Leblanc A, Valdez J, Perdigón G. 2004. Inflammatory immune response. Euro J Inflammation 2:21-31.
5. Feghali CA, Wright TM. 1997. Cytokines in acute and chronic inflammation. Frontiers i. Biosci 2:12-26.
6. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 11:1953-1960.
7. Hayatsu H, Hayatsu T. 1993. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground in the human. Cancer Lett 73:173-179.
8. Issacson P. 1982. Immunoperoxidase study of the secretory immunoglobulin system and lisozyme in normal and diseased gastric mucosa. Gut 23:578-583.
9. Kato I. 2000. Antitumour activity of lactic acid bacteria. In: Fuller R, Perdigón G, editors. Probiotics 3: Immunomodulation by the gut microflora and probiotics. London: Kluwer Academic Publishers. p 115-138.
10. Kato I, Endo K, Yokokura T. 1994. Effects of oral administration of Lactobacillus casei on antitumour effects induced by tumour resection in mice. Int J Immunopharmacol 16:29-32.
11. Kato I, Kobayashi S, Yokokura T, Mutai M. 1981. Antitumor activity of Lactobacillus casei in mice. Gann 72:517-523.
12. Kato I, Yokokura T, Mutai M. 1984. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol Immunol 28:209-217.
13. Masuno T, Kishimoto S, Ogura T, Honma T, Niitani H, Fukouka M, Ogawa N. 1991. A comparative trial of LC 9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung. Cancer 68:1495-1500.
14. Matsuzaki T, Yokokura T, Azuma I. 1985. Antitumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol Immunother 20:18-22.
15. Parker SL, Tong T, Bolden S, Wong PA. 1996. Cancer Statistics. CC-A Cancer J Clin 397:5-27.
16. Perdigón G, Jorrat M de, Petrino S, Rachid M. 1993. Antitumour activity of orally administered Lactobacillus casei: Significance of its dose in the inhibition of a fibrosarcome in mice. Food Agric Immunol 5:39-49.
17. Perdigón G, Jorrat ME de, Valdez JC, Budeguer M de, Oliver G. 1995. Cytolytic effect of the serum of mice fed with Lactobacillus casei on tumour cells. Microbiol Aliments Nutrition 13:15-24.
18. Perdigón G, Valdez JC, Rachid M. 1998. Antitumor activity of yogurt. Study of possible immune mechanisms. J Dairy Res 65:129-138.
19. Perdigón G, Maldonado Galdeano C, Valdez JC, Medici M. 2002. Interaction of lactic acid bacteria with the gut immune system. Euro J Clin Nutrition 56:21-26.
20. Pool-Zobel BL, Munzner R, Holzapfel WH. 1993. Antigenotoxic properties of latic acid bacteria in the S. Typhimurium mutagenicity assay. Nutrit Cancer 74:261-270.
21. Sainte-Marie G. 1962. A paraffin embedding technique for studies employing immuno fluorescence. J Histochem Cytochem 10:150-156.
22. Seller W, Fisher DE. 1999. Apoptosis and cancer drug targeting. J Clin Investigation 104:1655-1661.
23. Urban J, Shephard H, Rothstein J, Sugarman B, Schreiber H. 1986. Tumor necrosis factor a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83:5233-5237.
24. Yasutake N, Kato I, Ohwaki M, Yokokura T, Mutai M. 1984. Host-mediated antitumor activity of Lactobacillus casei in mice. Gann 75:72-80.
25. Yasutake N, Ohwaki M, Mutai M, Koide Y, Yoshida T. 1985. Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator in mice. Cancer Immunol Immunother 20:109-116.
26. Yasutake N, Matsukaki T, Kimura K, Hashimoto S, Yokokura T, Yoshikai Y. 1999. The role of tumour necrosis factor (TNF) in the antitumour effect of intrapleural injection of Lactobacillus casei strain in mice. Med Microbiol Immunol 188:9-14.